A novel highly bio‐available itraconazole formulation (SUBA®‐Itraconazole) for anti‐fungal prophylaxis in lung transplant recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel highly bio‐available itraconazole formulation (SUBA®‐Itraconazole) for anti‐fungal prophylaxis in lung transplant recipients

Published:2021-03 Issue:4 Volume:23 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Whitmore Timothy James¹²³^ORCID,Yaw Meow³,Lavender Melanie³,Musk Michael³,Boan Peter¹²,Wrobel Jeremy³⁴

Affiliation:

1. Department of Infectious Diseases Fiona Stanley Hospital Perth WA Australia

2. Department of Microbiology PathWest Laboratory Medicine WA Perth WA Australia

3. Department of Respiratory Medicine Fiona Stanley Hospital Perth WA Australia

4. School of Medicine University of Notre Dame Australia Fremantle WA Australia

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13587

Reference48 articles.

1. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match

2. Lung transplant: the Western Australian experience

3. ICU Care Before and After Lung Transplantation

4. Lung transplantation at Duke

5. Fungal Infections After Lung Transplantation

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SUBA-itraconazole in the treatment of systemic fungal infections;Future Microbiology;2024-07-16

2. Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-08-14

3. Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO);Journal of Antimicrobial Chemotherapy;2023-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3